CN107252038A - 一种适于糖尿病人群的功能食品 - Google Patents
一种适于糖尿病人群的功能食品 Download PDFInfo
- Publication number
- CN107252038A CN107252038A CN201710391583.9A CN201710391583A CN107252038A CN 107252038 A CN107252038 A CN 107252038A CN 201710391583 A CN201710391583 A CN 201710391583A CN 107252038 A CN107252038 A CN 107252038A
- Authority
- CN
- China
- Prior art keywords
- parts
- face
- functional food
- food
- sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 30
- 235000013376 functional food Nutrition 0.000 title claims abstract description 21
- 235000012149 noodles Nutrition 0.000 claims abstract description 11
- 244000068988 Glycine max Species 0.000 claims abstract description 10
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 10
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 10
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 10
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 10
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 10
- 240000004922 Vigna radiata Species 0.000 claims abstract description 10
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims abstract description 10
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 240000004638 Dendrobium nobile Species 0.000 claims abstract description 9
- 235000013312 flour Nutrition 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 9
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 7
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 7
- 238000012545 processing Methods 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 4
- 235000000346 sugar Nutrition 0.000 claims description 15
- 235000015895 biscuits Nutrition 0.000 claims description 5
- 235000015099 wheat brans Nutrition 0.000 claims description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 2
- 240000008620 Fagopyrum esculentum Species 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 14
- 230000036541 health Effects 0.000 abstract description 5
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 description 22
- 239000008103 glucose Substances 0.000 description 20
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 14
- 235000001727 glucose Nutrition 0.000 description 11
- 102000004877 Insulin Human genes 0.000 description 10
- 108090001061 Insulin Proteins 0.000 description 10
- 229940125396 insulin Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 6
- 235000013402 health food Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- -1 glucose monosaccharide Chemical class 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229960004329 metformin hydrochloride Drugs 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000107 myocyte Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- WKNQKPAPFFKRBJ-DPMUJHKHSA-N 6-Hydroxydendroxine Natural products O=C1O[C@@H]2[C@@H](C(C)C)[C@H]1[C@@]1(O)[C@]3(C)[C@@H](CN4[C@]23OCC4)CC1 WKNQKPAPFFKRBJ-DPMUJHKHSA-N 0.000 description 1
- WKNQKPAPFFKRBJ-UHFFFAOYSA-N 6-Oxy-dendroxin Natural products CC12C3(O)CCC2CN2CCOC12C1C(C(C)C)C3C(=O)O1 WKNQKPAPFFKRBJ-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- CCEAFOJVRQZWQC-UHFFFAOYSA-N Ddendroxine Natural products CC12C3CCC2CN2CCOC12C1C(C(C)C)C3C(=O)O1 CCEAFOJVRQZWQC-UHFFFAOYSA-N 0.000 description 1
- QSNCUGULHPBRGR-UHFFFAOYSA-N Dendramine Natural products CC12C3(O)CCC2CN(C)C1C1C(C(C)C)C3C(=O)O1 QSNCUGULHPBRGR-UHFFFAOYSA-N 0.000 description 1
- IAIIJNHQMKXPHL-JMMPBUAGSA-N Dendrine Natural products O=C(OC)C[C@@H]1N(C)[C@H]2[C@@]3(C)[C@@H]1CC[C@H]3[C@H]1[C@H](C(C)C)[C@H]2OC1=O IAIIJNHQMKXPHL-JMMPBUAGSA-N 0.000 description 1
- RYAHJFGVOCZDEI-UFFNCVEVSA-N Dendrobine Chemical compound C([C@H]1CC[C@@H]2[C@@]31C)N(C)[C@@H]3[C@H]1[C@@H](C(C)C)[C@@H]2C(=O)O1 RYAHJFGVOCZDEI-UFFNCVEVSA-N 0.000 description 1
- 241001523681 Dendrobium Species 0.000 description 1
- 241000026010 Dendrobium candidum Species 0.000 description 1
- CCEAFOJVRQZWQC-KFYGABLUSA-N Dendroxine Natural products O=C1O[C@@H]2[C@@H](C(C)C)[C@@H]1[C@H]1[C@]3(C)[C@@H](CN4[C@]23OCC4)CC1 CCEAFOJVRQZWQC-KFYGABLUSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000219051 Fagopyrum Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 240000003915 Lophatherum gracile Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- MAEQVSBPCIMMJF-UHFFFAOYSA-N Nobilonin Natural products CC(C)C1C2C(=O)C3(C)C(CN(C)C)CCC3C1C(=O)O2 MAEQVSBPCIMMJF-UHFFFAOYSA-N 0.000 description 1
- MAEQVSBPCIMMJF-MSZYXCAISA-N Nobilonine Natural products O=C1[C@@]2(C)[C@@H](CN(C)C)CC[C@H]2[C@H]2[C@H](C(C)C)[C@H]1OC2=O MAEQVSBPCIMMJF-MSZYXCAISA-N 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001165494 Rhodiola Species 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- RYAHJFGVOCZDEI-CZKZLRAZSA-N dendrobine Natural products O=C1O[C@@H]2[C@H](C(C)C)[C@H]1[C@H]1[C@@]3(C)[C@@H]2N(C)C[C@H]3CC1 RYAHJFGVOCZDEI-CZKZLRAZSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960000346 gliclazide Drugs 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000019680 high-energy food Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 208000006443 lactic acidosis Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/12—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops of potatoes
- A23L19/15—Unshaped dry products, e.g. powders, flakes, granules or agglomerates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种适于糖尿病人群的功能食品，其特征在于由下述重量份原料加工而成：苦荞面20‑30份、燕麦面20‑25份、土豆粉10‑20份、绿豆面20‑25份、黑豆面20‑25份、麸面10‑15份、伏牛山石斛3‑5份、葛根粉3‑5份。本发明组方是通过以上药食两用食材按科学的比例组配而成，从而达到为糖友患者提供一种保健有效的功能食品。与现有技术相比，具有科学搭配，功能齐全，无副作用的特点。
Description
技术领域
本发明涉及到一种适于糖尿病人群的功能食品，属于保健品技术领域。本发明可以制备成保健食品，主要适用于糖尿病患者人群。
背景技术
糖尿病是一组以高血糖为特征的代谢性疾病。高血糖则是由于胰岛素分泌缺陷或其生物作用受损，或两者兼有引起。糖尿病时长期存在的高血糖，导致各种组织，特别是眼、肾、心脏、血管、神经的慢性损害、功能障碍。糖尿病患者在我国现阶段发病率极高，据统计全国糖尿病患者已突破1亿人，我国已成为世界糖尿病最多的国家。
糖尿病的病因与胰岛素的关系比较密切，胰岛素是调节大多数组织细胞 ( 主要是肌细胞和脂肪细胞，不包括中枢神经***的神经元细胞 ) 吸收葡萄糖的主要激素，所以胰岛素缺乏和细胞受体对胰岛素不敏感在所有类型的糖尿病中都扮演着重要的角色。大多数食物中的碳水化合物在几个小时之内就会被转化成葡萄糖单糖——一种在血液中主要的碳水化合物。也有一些碳水化合物不能转化，例如果糖 (fructose)，虽然其也能作为细胞能量来源，但是并不会转换为葡萄糖，也不参与胰岛素 - 葡萄糖调节机制。另外，纤维素也不能被转换成葡萄糖，虽然其是由许多葡萄糖分子组成的长链，这是因为人类和许多动物的消化道没有能力消化它。当血液中葡萄糖的浓度升高时，比如饭后，β细胞就释放胰岛素到血液中。胰岛素使得大多数的细胞 ( 通常的估计是全身 2/3 的细胞，包括肌细胞和脂肪组织 ) 从血液中吸收葡萄糖作为他们的能量，或者转化成其它人体所需要的分子，或者储存起来。胰岛素也是葡萄糖和储存于肝脏和肌肉细胞中的肝糖之间相互转换的主要控制信号，血糖浓度降低既会导致胰岛β细胞减少释放胰岛素，也会降低葡萄糖向肝糖的转化。高胰岛素水平可以加速多种生化合成的过程，比如细胞的生长和***、蛋白质合成和脂肪形成等。糖尿病总的治疗原则是通过改变生活方式，包括饮食控制、体育锻炼、减轻体重，不吸烟及避免二手烟对预防及控制糖尿病也有一定的效果，并配合一定的药物治疗，以达到控制血糖、预防并发症的目的。常用的治疗方法有：1、磺脲类——格列齐特等，作用机制：刺激胰岛素β细胞释放和分泌胰岛素，是血糖水平迅速降低。不良反应：β细胞功能衰竭；低血糖等。2、双胍类——盐酸二甲双胍等作用机制：延缓葡糖糖在肠道的吸收。不良反应：恶心、呕吐等胃肠道反应；乳酸性酸中毒等。3、α- 葡萄糖干酶抑制剂——阿卡波糖等，作用机制：延缓消化道对糖的吸收。不良反应：胃肠道不适，恶心，腹泻等。4、中医治疗——恒 CN104258145 A 说明书 4 2/6 页 5 济悦泰胶囊等，作用机制：调节胰岛分泌功能，保肝护肾，调节脏腑代谢机能等，中医治疗糖尿病具有副作用小，效果显著。
目前糖尿病人吃不敢吃，喝不敢喝，食品选择造成了极大的思想压力。提供一种适应不同体质、不同病患程度糖尿病患者食用的糖友保健食品，在社会上有着广泛的需求。申请公布号 CN 104258145 A 申请公布日 2015.01.07公开了一种制备治疗糖尿病的保健食品，由淡竹叶、赤小豆、红景天、西洋参、桃仁五味中药组成，该中药组合物可以制备成保健食品或药品，实验研究表明，本发明保健食品能够有效治疗糖尿病。该保健食品本质上还是由中医成份构成，非真正意义上的食品。
发明内容
为解决现有技术存在的问题，本发明的目的在于提供一种适于糖尿病人群的功能食品，升糖指数低，可平和糖尿病患者心态，提升糖友生活质量。
为实现上述目的，本发明采用的技术方案：该糖友功能食品，其特征在于由下述重量份原料加工而成：苦荞面20-30份、燕麦面20-25份、土豆粉10-20份、绿豆面20-25份、黑豆面20-25份、麸面10-15份、伏牛山石斛3-5份、葛根粉3-5份。
优选的，该糖友功能食品，由下述重量份原料加工而成：苦荞面25份、燕麦面22份、土豆粉15份、绿豆面20份、黑豆面25份、麦麸面15份、石斛4份、葛根粉4份。
将上述重量份的原料制成面条或饼干功能食品。
采用上述技术方案的有益效果：该适于糖尿病人群的功能食品采用食用及药食两用食品原料制成，其中，若荞面，味苦，在所有谷类中，被称为最具营养的食物，富含氨基酸、维生素和大量黄酮类化合物，能增强胰岛素的活性，加速糖代谢，促进脂肪和蛋白质的合成。燕麦面是由燕麦磨制而成，具有补虚、收敛止血，固表止汗的功效，是一种低糖、高营养高能食品。土豆粉是土豆加工而成，富含蛋白质、赖氨酸和氨酸，富含丰富的膳食纤维，所含的热量比较低，吃再多也不必担心摄入脂肪过多，还能增强饱腹感，减少食物摄入量，被营养学者誉为“十全十美的食物”。绿豆面是由绿豆加工而成，富含蛋白质、多糖和磷脂，是一种具有清热解毒功效的营养食品。黑豆面是由黑豆加工而成，富含丰富的维生素和花青素，是很好的的抗氧剂来源，能清除体内自由基，可提供食物中大量的精纤维，促进消化，增加肠胃蠕动，是一种非常好的保健食品。麸面是由小麦加式而成，富含淀粉、蛋白质、面筋、膳食纤维、B族维生素，在体内发挥着许多功能，而且还是食物正常代谢中不可缺少的营养成分。是人体必需的营养元素，可提高食物中的纤维成分，可改善大便秘结情况，同时可促使脂肪及氮的***，对临床常见纤维缺乏性疾病的防治作用意义重大，可以使血清胆固醇下降，动脉粥样硬化的形成减慢。有改善大便秘结、预防结肠癌、直肠癌及乳腺癌、使血清胆固醇下降，动脉粥样硬化的形成减慢的功效。石斛主要药用有效成分为石斛多糖，含石斛碱、石斛胺、石斛次碱、石斛星碱、石斛因碱、6-羟石斛星碱，尚含粘液质、淀粉。滋阴补虚,有显著的免疫增强活性和抗癌活性，被誉为“九大仙草”之首。《神农本草经》记载,铁皮石斛“主伤中、除痹、下气、补五脏虚劳羸瘦、强阴、久服厚肠胃”。李时珍在《本草纲目》中评价铁皮石斛“强阴益精,久服,厚肠胃,补内绝不足,平胃气,长肌肉,逐皮肤邪热痱气,脚膝疼冷痹弱,定智除惊,轻身延年。益气除热,健阳,逐皮肤风痹,骨中久冷,补肾益力。葛根粉，甘、辛，凉。有解肌退热，透疹，生津止渴，升阳止泻之功。常用于表证发热，项背强痛，麻疹不透，热病口渴，阴虚消渴，热泻热痢，脾虚泄泻。《本草经疏》：“葛根，解散阳明温病热邪主要药也，故主消渴，身大热，热壅胸膈作呕吐。发散而升，风药之性也，故主诸痹。”“伤寒头痛兼项强腰脊痛，及遍身骨疼者，足太阳也，邪犹未入阳明，故无渴证，不宜服。”
本发明组方是通过以上药食两用食材按科学的比例组配而成，从而达到为糖友患者提供一种保健有效的功能食品。与现有技术相比，具有科学搭配，功能齐全，无副作用的特点。
试验例
为阐明本发明保健食品具有治疗糖尿病的效果，用按实施例 1 方法所制得的功能食品进行了下列试验。
1 资料与方法
1.1 一般资料选取 120 例糖尿病患者，将患者随机分为治疗组和对照组。治疗组 70例，男 38 例，女 32 例，平均年龄为 (48.8±5.1) 岁，肥胖型患者 38 例；对照组 70 例，男 37 例，女 33 例，平均年龄为 (49.3±6.8) 岁，肥胖型患者 36 例，经统计，两组在上述基本资料方面无显著性差异 (P>0.05)，具有可比性。
1.2 治疗方法对照组使用盐酸二甲双胍片 (250m g/ 片，250mg/ 次，每日 3 次。治疗组在对照组基础上加用本发明制成饼干，2块，每块50克，3 次 / 日，疗程均为 3 个月。
1.3 观察指标：
(1) 治疗前后分别检查 FPG( 空腹血糖 )、P2hPG( 餐后 2 小时血糖 ) ；
(2) 相关临床症状 ( 包括口渴多饮、多食易饥、五心烦热、倦怠乏力 ) 积分比较。
1.4 疗效判定标准：
参照*** 1993 年《中药新药临床研究指导原则》进行疗效判断。显效：治疗后症状基本消失，空腹血糖 <7.2mmol/L，餐后2h 血糖<8.3mmol/L ；有效：空腹血糖<8.0mmol/L，餐后2h 血糖<10.0mmol/L ；无效：治疗后症状无改善，且空腹血糖及餐后血糖未达到上述标准者。症状疗效评定按四级评分法分级：0( 无症状)、1( 须经提醒时方能感觉症状存在)、2( 有时有症状)、3( 症状明显)，并进行症状计分和积分。
1.5 统计学处理采用SPSS13.0 统计软件进行数据处理，计量资料以均数±标准差() 表示，采用t 检验，计数资料采用x2 检验。
2 结果
2.1 临床疗效比较经统计，治疗组患者总有效率明显高于对照组(P ＜ 0.05)。结果见表1。
表1 两组患者临床疗效比较(％ )
注：与对照组比较*P ＜ 0.05
2.2 治疗前后血糖变化经统计，治疗组与对照组相比，FPG、P2hPG 明显降低(P
＜ 0.05)。结果见表2。
表2 两组患者血糖的比较()
注：与对照组比较*P ＜ 0.05，与治疗前比较﹟ P ＜ 0.05。
2.3 治疗前后临床症状变化经统计，治疗组与对照组相比，各临床症状明显改善
(P ＜ 0.05)，说明本发明药物可明显改善患者的临床症状。结果见表3。
表3 两组患者临床症状积分的比较()
注：与对照组比较*P ＜ 0.05，与治疗前比较﹟P＜ 0.05。
3 结论
本临床试验是在西医常规治疗的基础上，配合本发明功能食品治疗，在提高临床疗效、降低血糖及改善患者临床症状等方面均优于单纯西医治疗，充分证实本发明功能对糖尿病具有显著的临床疗效。
具体实施方式
下述实施例用于举例说明本发明糖友功能食品的制备，但其不能对本发明的范围构成任何限制。
实施例1
一种适于糖尿病人群的功能食品，由下述重量份原料加工而成：苦荞面20份、燕麦面20份、土豆粉10份、绿豆面20份、黑豆面20份、麸面10份、石斛3份、葛根粉3份。将上述重量份的原料制成面条或饼干功能食品。
实施例2
一种适于糖尿病人群的功能食品，苦荞面25份、燕麦面22份、土豆粉15份、绿豆面20份、黑豆面25份、麦麸面15份、石斛4份、葛根粉4份。
将上述重量份的原料制成面条或饼干功能食品。
实施例3
一种适于糖尿病人群的功能食品，由下述重量份原料加工而成：苦荞面30份、燕麦面25份、土豆粉20份、绿豆面25份、黑豆面25份、麸面15份、石斛5份、葛根粉5份。
Claims (3)
1.一种用于治疗糖尿病的糖友功能食品，其特征在于由下述重量份原料加工而成：苦荞面20-30份、燕麦面20-25份、土豆粉10-20份、绿豆面20-25份、黑豆面20-25份、麸面10-15份、伏牛山石斛3-5份、葛根粉3-5份。
2.如权利要求1所述的用于治疗糖尿病的糖友功能食品，其特征在于由下述重量份原料加工而成：苦荞面25份、燕麦面22份、土豆粉15份、绿豆面20份、黑豆面25份、麦麸面15份、石斛4份、葛根粉4份。
3.如权利要求1所述的用于治疗糖尿病的糖友功能食品，其特征在于将上述重量份的原料制成面条或饼干功能食品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710391583.9A CN107252038A (zh) | 2017-05-27 | 2017-05-27 | 一种适于糖尿病人群的功能食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710391583.9A CN107252038A (zh) | 2017-05-27 | 2017-05-27 | 一种适于糖尿病人群的功能食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107252038A true CN107252038A (zh) | 2017-10-17 |
Family
ID=60027456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710391583.9A Pending CN107252038A (zh) | 2017-05-27 | 2017-05-27 | 一种适于糖尿病人群的功能食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107252038A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107853693A (zh) * | 2017-11-17 | 2018-03-30 | 广西顺昌隆生物科技有限公司 | 一种铁皮石斛代餐粉及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1543856A (zh) * | 2003-11-10 | 2004-11-10 | 歌 宋 | 一种用于糖尿病及心脑血管病辅助治疗的营养保健食品 |
| CN102113648A (zh) * | 2009-12-30 | 2011-07-06 | 徐秀卿 | 一种适合“五高”代谢综合症人群的特膳面条及其制备方法 |
-
2017
- 2017-05-27 CN CN201710391583.9A patent/CN107252038A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1543856A (zh) * | 2003-11-10 | 2004-11-10 | 歌 宋 | 一种用于糖尿病及心脑血管病辅助治疗的营养保健食品 |
| CN102113648A (zh) * | 2009-12-30 | 2011-07-06 | 徐秀卿 | 一种适合“五高”代谢综合症人群的特膳面条及其制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107853693A (zh) * | 2017-11-17 | 2018-03-30 | 广西顺昌隆生物科技有限公司 | 一种铁皮石斛代餐粉及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017101389A4 (en) | Specialized flour for nutrition meals for diabetes and preparation method and use thereof | |
| CN100579395C (zh) | 一种具有稳定餐后血糖的方便营养粥及其制备方法 | |
| CN108112996A (zh) | 一种控制2型糖尿病人群高血糖和提高免疫力的营养组合物 | |
| CN102919836B (zh) | 一种降糖、降压、降脂、通便养颜、减肥、抗疲劳保健品及其生产工艺 | |
| CN101744170B (zh) | 一种适于糖尿病人的苦荞八宝粥及其制作方法 | |
| CN103099089B (zh) | 一种降糖、降压、通便减肥、抗疲劳、改善性功能保健品及其生产工艺 | |
| EP3626249A2 (en) | Traditional chinese medicine healthcare preparation for fat elimination and weight reduction | |
| CN107373376A (zh) | 一种糖尿病营养配方米及其制备和烹制方法 | |
| CN103445170B (zh) | 健脾养胃粉 | |
| CN106038704A (zh) | 一种用于抑制食物消化吸收的组合物、制备方法及用途 | |
| CN102526478B (zh) | 一种增强免疫力、降血糖功能的保健药物配方 | |
| CN1802934A (zh) | 糖尿病食疗营养面包饼 | |
| CN108095113A (zh) | 一种具有减脂降糖作用的组合物、制剂及其应用 | |
| CN1814167A (zh) | 一种用于糖尿病的保健品 | |
| CN108392519A (zh) | 一种降血糖组合物及其制备和应用 | |
| CN107752024A (zh) | 一种改善三高及肥胖等代谢异常疾病的营养代餐食品 | |
| CN102461587A (zh) | 预防糖尿病用富硒桑叶黑粮面制食品 | |
| CN102526479A (zh) | 一种增强免疫力、降血糖功能的保健药物配方 | |
| CN108524673A (zh) | 一种中药组合物及其应用 | |
| CN111543605A (zh) | 一种四高或肥胖人群用综合营养粉 | |
| CN106387900A (zh) | 一种调节血脂、血压及血糖的组合物及其应用 | |
| CN103535576B (zh) | 花粉代餐粉 | |
| CN103053638B (zh) | 一种恢复胰岛功能消除胰岛素抵抗的面粉及其制法 | |
| CN106954786A (zh) | 杂粮粉及其制备方法 | |
| CN107252038A (zh) | 一种适于糖尿病人群的功能食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171017 |